Brain Navi Biotechnology
Brain Navi Biotechnology is a Taiwan-based surgical robotics company that develops and markets the NaoTrac autonomous neurosurgical navigation robot and KrystoLens single-use neuro-endoscope, serving neurosurgery departments in hospitals across Asia, Europe, and the Americas.
- Company typePrivate
- Founded2015
- HeadquartersHsinchu, Taiwan
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Brain Navi Biotechnology firmographics
Firmographics- Name
- Brain Navi Biotechnology
- Legal name
- Brain Navi Biotechnology Co., Ltd.
- Website
- https://brainnavi.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Brain Navi Biotechnology is a Taiwan-based surgical robotics company that develops and markets the NaoTrac autonomous neurosurgical navigation robot and KrystoLens single-use neuro-endoscope, serving neurosurgery departments in hospitals across Asia, Europe, and the Americas.
- Ownership category
- akta.pro rank
Brain Navi Biotechnology industry classification
Industry- Product category
- Surgical Robotics - Neurosurgical Navigation
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)
Keywords
Where Brain Navi Biotechnology is headquartered
LocationHeadquarters
- HQ city
- Hsinchu
- HQ country
- Taiwan
- HQ region
- Asia
Offices1 record
Markets served
Brain Navi Biotechnology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- NaoTrac Surgical Navigation Robot Sales: Sale of NaoTrac autonomous neurosurgical navigation robot systems to hospitals and medical centers
- KrystoLens Consumables: Single-use disposable neuro-endoscope product line generating recurring consumable revenue
- Service and Support: Installation, training, and ongoing technical support services for NaoTrac system
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Medical device enterprise sales - custom quotation |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels6 records
Brain Navi Biotechnology product offering
Product offeringCore offering
Brain Navi Biotechnology designs, manufactures, and sells robotic neurosurgical navigation systems and neuro-endoscopes for hospital neurosurgery departments. Its flagship product NaoTrac is an autonomous neurosurgical navigation robot that uses machine vision and the proprietary SMART (Surface Mapping Auto-registration Technology) platform to enable non-contact patient registration and sub-millimeter surgical pathway navigation through 1cm keyhole incisions. Its complementary product KrystoLens is the first single-use 2D/3D neuro-endoscope for intracranial visualization, sold as a recurring disposable consumable.
Product overview
Brain Navi Biotechnology is a surgical robotics company offering a portfolio of neurosurgical products centered on two main platforms: NaoTrac (autonomous surgical navigation robot) and KrystoLens (single-use neuro-endoscope), both built on the proprietary SMART (Surface Mapping Auto-registration Technology) platform. NaoTrac provides AI-powered surgical navigation with machine vision-based patient registration, while KrystoLens offers disposable endoscopic visualization. The products serve hospitals and surgical centers performing neurosurgical procedures including brain tumor biopsies, deep brain stimulation, EVD placement, ICH treatment, and stem cell implantation.
Differentiator
Problem solved
Functional benefit
Brands
- NaoTrac: Autonomous neurosurgical navigation robot using machine vision and 3D positioning for brain surgery navigation.
- KrystoLens
- SMART Technology
Products and services
- NaoTrac Surgical Navigation Robot Autonomous neurosurgical navigation robot for hospital neurosurgery departments. Uses machine vision and the proprietary SMART (Surface Mapping Auto-registration Technology) platform to enable non-contact patient registration and autonomously navigate to lesion targets through 1-centimeter keyhole incisions, achieving sub-0.5mm registration accuracy. Supports brain tumor biopsy, deep brain stimulation, EVD placement, ICH evacuation, and stereotactic neurosurgery.
- KrystoLens Single-Use Neuro-Endoscope First single-use 2D/3D disposable neuro-endoscope with a wide-angle surgical working channel (8.5mm x 4.7mm) for intracranial surgery visualization. Designed for ventriculostomies, biopsies, removal of cysts, tumors, and other obstructions, providing dual-lens 3D view to neurosurgeons.
- AOARM Educational Training Platform Educational training platform linked from Brain Navi's product menu for surgeon training and continuing education on the NaoTrac neurosurgical navigation system.
Quantifiable outcome
- Patient registration time reduced from 49.1 minutes to 2.4 minutes
- +6 more outcomes
Companies that use Brain Navi Biotechnology
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
Brain Navi Biotechnology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature7 records
Brain Navi Biotechnology partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered strategic, core, secondary and flagship.
- Startup Island TAIWANstrategicMOU with City of Phoenix, Greater Phoenix Economic Council, and Tesoro Venture Capital to strengthen cross-border collaboration in AI, semiconductors, and health-tech startups. Part of Taiwan-U.S. innovation link initiative building on TSMC expansion in Phoenix.
- Palex HealthcarecoreSpain distribution partner for NaoTrac market entry in Europe. Led successful first NaoTrac surgeries in Spain and ongoing commercialization efforts in Spanish market.
- BenQ Medical TechnologycoreStrategic partnership to introduce and commercialize NaoTrac neurosurgical navigation robot in the Chinese market. BenQ Medical Technology leverages its extensive hospital network across China for clinical deployment. Supported by China's 14th Five-Year Plan for Medical Equipment Industry development.
- Avalue HealthcaresecondaryTechnology partnership using Avalue Healthcare's Medical Edge AI PC MAB-T600 to enable real-time 3D imaging, robotic-assisted navigation, and AI-driven machine vision capabilities.
- Mayo Clinic and ASU MedTech AcceleratorflagshipSelected for prestigious medical technology accelerator program. Provides access to clinical expertise, research capabilities, and US market development support through Mayo Clinic and Arizona State University partnership.
- Bestchain HealthTaiwancoreGeneral distributor partnership covering Taiwan market. Part of Bestchain Medical Group for comprehensive distribution of Brain Navi products in Taiwan.
- SMHeuristicssecondaryBoise-based partner for sales and marketing efforts in the United States medical device market. MOU signed for further sales cooperation.
- Hualien Tzu-Chi Medical CentercoreKey clinical partner for first-in-human trial (2018) and ongoing clinical research. Published pilot study results in Acta Neurochirurgica journal on EVD placement using NaoTrac SMART technology.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
Brain Navi Biotechnology competitors and assessment
Company assessmentBroad incumbents
- Medtronic (StealthStation): Medtronic's StealthStation is the dominant incumbent in image-guided neurosurgical navigation. While much broader in portfolio, StealthStation competes head-to-head with NaoTrac for neurosurgery hospital procurement and represents the legacy bone-fiducial-based paradigm Brain Navi is disrupting.
- Stryker: Stryker is a broad incumbent offering neurosurgical navigation, surgical instruments, and visualization (including neuro-endoscopy via acquired assets). Comparable in targeting the neurosurgery OR with an integrated hardware-and-consumables portfolio.
Emerging players
- Penumbra (REAL System): Penumbra's REAL Immersive System is a robotic-assisted neurosurgery navigation platform with partial overlap to NaoTrac. Both are emerging players pursuing workflow-disrupting neurosurgical navigation, with Penumbra leveraging a strong neurovascular commercial channel.
- Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS is an image-guided robotic navigation platform with growing cranial applications. Comparable as a smaller, focused surgical robotics competitor to NaoTrac in image-guided neurosurgery, with overlapping hospital procurement channels.
Direct peers
- Brainlab: Brainlab offers the Curve and Kick navigation systems used widely in neurosurgery ORs globally. Direct overlap with NaoTrac in surgical navigation for cranial procedures; comparable in targeting neurosurgery departments with image-guided workflow solutions.
- Renishaw: Renishaw's neuromate system is one of the closest direct competitors — a dedicated stereotactic neurosurgical robot used for biopsy, DBS, and SEEG. Comparable in being a focused, capital-equipment neurosurgical navigation/robotics player targeting hospital neurosurgery departments.
- Synaptive Medical: Synaptive's Modus V and BrightMatter platforms combine neurosurgical navigation, robotics, and visualization — a near-perfect analog of Brain Navi's NaoTrac + KrystoLens pairing. Both target precision neurosurgery with workflow-enhancing technology for hospitals.
- Karl Storz: Karl Storz is the established leader in rigid neuro-endoscopy — directly comparable to Brain Navi's KrystoLens single-use neuro-endoscope line. Both target neurosurgical visualization, though Karl Storz leads in reusable scopes while KrystoLens is differentiated as a single-use 3D platform.
- Zimmer Biomet (ROSA Robotics): Zimmer Biomet's ROSA platform includes a ROSA Brain module for neurosurgical procedures — a directly comparable robotic neurosurgery assistant. Comparable business model selling robotic capital equipment to hospitals and competing for the same neurosurgery budget line.
Regional players
- THINK Surgical: THINK Surgical develops open-platform surgical robotics for orthopedic procedures; methodologically comparable as a focused, independent surgical robotics company with a similar capital-equipment-plus-consumables business model, though primarily US-focused and orthopedic rather than neurosurgical.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Brain Navi Biotechnology social profiles
Digital presenceBrain Navi Biotechnology compliance and trust
Trust signalCompliance6 records
Brain Navi Biotechnology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Brain Navi Biotechnology leadership team
Management profileNumber of profiles
Profiles8 records
Brain Navi Biotechnology funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Brain Navi Biotechnology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Brain Navi Biotechnology
What does Brain Navi Biotechnology do?
Brain Navi Biotechnology designs, manufactures, and sells robotic neurosurgical navigation systems and neuro-endoscopes for hospital neurosurgery departments. Its flagship product NaoTrac is an autonomous neurosurgical navigation robot that uses machine vision and the proprietary SMART (Surface Mapping Auto-registration Technology) platform to enable non-contact patient registration and sub-millimeter surgical pathway navigation through 1cm keyhole incisions. Its complementary product KrystoLens is the first single-use 2D/3D neuro-endoscope for intracranial visualization, sold as a recurring disposable consumable.
Is Brain Navi Biotechnology a public or private company?
Brain Navi Biotechnology is a private company. It is classified as venture growth investor backed and is currently operating.
When was Brain Navi Biotechnology founded?
Brain Navi Biotechnology was founded in 2015. It employs 11 to 50 people.
Where is Brain Navi Biotechnology based?
Brain Navi Biotechnology is headquartered in Hsinchu, Taiwan, in the Asia region.
How does Brain Navi Biotechnology make money?
Three revenue lines are on record. NaoTrac Surgical Navigation Robot Sales are the primary driver. The others are krystoLens Consumables and service and Support.
Who are Brain Navi Biotechnology's main competitors?
Broad incumbents on record are Medtronic (StealthStation) and Stryker. Emerging players are Penumbra (REAL System) and Globus Medical (ExcelsiusGPS). Direct peers are Brainlab, Renishaw, Synaptive Medical, Karl Storz and Zimmer Biomet (ROSA Robotics). THINK Surgical is listed as a regional player.
Does Brain Navi Biotechnology have an API?
No public API is recorded for Brain Navi Biotechnology.
What industry is Brain Navi Biotechnology in?
Brain Navi Biotechnology's product category is Surgical Robotics - Neurosurgical Navigation. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT). Its NAICS code is 339112 and its SIC code is 3841.